MPI Research has acquired and implemented a Gyrolab xP workstation from Gyros AB into its time-critical project workflows. Gyros provides microfluidic technologies to miniaturize and automate immunoassays. Alan Breau, MPI’s vice president for Bioanalytical/Analytical Services said, “Data from immunoassays underpin many critical decisions within complex project workflows. Our goal as a CRO is to deliver high quality results as rapidly and cost-effectively as possible to our clients in the bio...